Rapid and quantitative phage susceptibility test by ramanome

Abstract

Antimicrobial resistance poses an escalating global threat, renewing interest in bacteriophage therapy as a precision alternative to antibiotics. However, clinical translation remains hindered by the lack of rapid and quantitative phage susceptibility testing (PST) platforms capable of evaluating host range, infection potency, and effective multiplicity of infection (MOI). Here, we present a ramanome-based phage susceptibility test (RPST), a phenotypic platform that captures infection-induced remodeling of bacterial macromolecular composition to unify these diagnostic requirements within a single workflow. RPST integrates four Raman biomarkers into a Composite Infection Index (CII), enabling rapid and lysis-independent discrimination between susceptible and resistant bacterial populations within ~1 h, with 96.0% categorical concordance (24/25) to plaque assays. As a continuous population-level metric, CII quantifies the proportion of infected cells, allowing quantitative ranking of phage potency against shared hosts. By resolving CII trajectories across the MOI and time, RPST further determines the minimal effective MOI, which is the lowest phage-to-bacterium ratio sustaining self-propagating infection, thereby defining the lower boundary for therapeutic feasibility. Together, these capabilities transform PST from static compatibility assays into a dynamic and quantitative framework that bridges in vitro infectivity assessment and infection dynamics relevant to phage therapy.

Keywords

antimicrobial resistance (AMR) / biomarker discovery / phage susceptibility test (PST) / precision phage therapy / ramanome

References

[1] Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022; 399: 629–655.

[2] Brown DG, Wobst HJ. A decade of FDA-approved drugs (2010-2019): trends and future directions. J Med Chem. 2021; 64: 2312–2338.

[3] MacNair CR, Rutherford ST, Tan M-W. Alternative therapeutic strategies to treat antibiotic-resistant pathogens. Nat Rev Microbiol. 2023; 22: 262–275.

[4] Ranveer SA, Dasriya V, Ahmad MF, Dhillon HS, Samtiya M, Shama E, et al. Positive and negative aspects of bacteriophages and their immense role in the food chain. NPJ Sci Food. 2024; 8: 1.

[5] Duan X, Liu W, Xiao Y, Rao M, Ji L, Wan X, et al. Exploration of the feasibility of clinical application of phage treatment for multidrug-resistant Serratia marcescens-induced pulmonary infection. Emerg Microbes Infect. 2025; 14:2451048.

[6] Strathdee SA, Hatfull GF, Mutalik VK, Schooley RT. Phage therapy: from biological mechanisms to future directions. Cell. 2023; 186: 17–31.

[7] Hickson SM, Ledger EL, Wells TJ. Emerging antimicrobial therapies for Gram-negative infections in human clinical use. NPJ Antimicrob Resist. 2025; 3: 16.

[8] Suh GA, Patel R. Clinical phage microbiology: a narrative summary. Clin Microbiol Infect. 2023; 29: 710–713.

[9] Rao GG, Vallé Q, Mahadevan R, Sharma R, Barr JJ, Van Tyne D. Crossing the chasm: how to approach translational pharmacokinetic-pharmacodynamic modeling of phage dosing. Clin Pharmacol Ther. 2025; 117: 94–105.

[10] Skurnik M, Alkalay-Oren S, Boon M, Clokie M, Sicheritz-Pontén T, Dąbrowska K, et al. Phage therapy. Nat Rev Methods Primers. 2025; 5: 9.

[11] Gelman D, Yerushalmy O, Alkalay-Oren S, Rakov C, Ben-Porat S, Khalifa L, et al. Clinical phage microbiology: a suggested framework and recommendations for the in-vitro matching steps of phage therapy. Lancet Microbe. 2021; 2: e555–e563.

[12] Wang XY, Yang JY, Wang YT, Zhang HC, Chen ML, Yang T, et al. M13 phage-based nanoprobe for SERS detection and inactivation of Staphylococcus aureus. Talanta. 2021; 221:121668.

[13] Skusa R, Groß J, Kohlen J, Schafmayer C, Ekat K, Podbielski A, et al. Proof-of-concept standardized approach using a single-disk method analogous to antibiotic disk diffusion assays for routine phage susceptibility testing in diagnostic laboratories. Appl Environ Microbiol. 2022; 88:e0030922.

[14] Low HZ, Böhnlein C, Sprotte S, Wagner N, Fiedler G, Kabisch J, et al. Fast and easy phage-tagging and live/dead analysis for the rapid monitoring of bacteriophage infection. Front Microbiol. 2020; 11:602444.

[15] Giergiel M, Chakkumpulakkal Puthan Veettil T, Rossetti A, Kochan K. Advanced vibrational spectroscopy and bacteriophages team up: dynamic synergy for medical and environmental applications. Int J Mol Sci. 2024; 25: 8148.

[16] Almaviva S, Palucci A, Aruffo E, Rufoloni A, Lai A. Bacillus thuringiensis cells selectively captured by phages and identified by surface enhanced Raman spectroscopy technique. Micromachines. 2021; 12: 100.

[17] Ilhan H, Tayyarcan EK, Caglayan MG, Boyaci İH, Saglam N, et al. Replacement of antibodies with bacteriophages in lateral flow assay of salmonella enteritidis. Biosens Bioelectron. 2021; 189:113383.

[18] Franco D, De Plano LM, Rizzo MG, Scibilia S, Lentini G, Fazio E, et al. Bio-hybrid gold nanoparticles as SERS probe for rapid bacteria cell identification. Spectrochim Acta A Mol Biomol Spectrosc. 2020; 224:117394.

[19] Jeon Y, Lee S, Vu NT, Kim H, Hwang IS, Oh C-S, et al. Label-free surface-enhanced Raman scattering detection of fire blight pathogen using a pathogen-specific bacteriophage. J Agricult Food Chem. 2024; 72: 2374–2380.

[20] Mehmood N, Akram MW, Majeed MI, Nawaz H, Aslam MA, Naman A, et al. Surface-enhanced Raman spectroscopy for the characterization of bacterial pellets of Staphylococcus aureus infected by bacteriophage. RSC Adv. 2024; 14: 5425–5434.

[21] Garg A, Nam W, Wang W, Vikesland P, Zhou W. In situ spatiotemporal SERS measurements and multivariate analysis of virally infected bacterial biofilms using nanolaminated plasmonic crystals. ACS Sens. 2023; 8: 1132–1142.

[22] Pienpinijtham P, Kitahama Y, Ozaki Y. Progress of tip-enhanced Raman scattering for the last two decades and its challenges in very recent years. Nanoscale. 2022; 14: 5265–5288.

[23] Alcolombri U, Pioli R, Stocker R, Berry D. Single-cell stable isotope probing in microbial ecology. ISME Commun. 2022; 2: 55.

[24] Zhu P, Ren L, Zhu Y, Dai J, Liu H, Mao Y, et al. Rapid, automated, and reliable antimicrobial susceptibility test from positive blood culture by CAST-R. mLife. 2022; 1: 329–340.

[25] Liu M, Zhu P, Zhang L, Gong Y, Wang C, Sun L, et al. Single-cell identification, drug susceptibility test, and whole-genome sequencing of Helicobacter pylori directly from gastric biopsy by clinical antimicrobial susceptibility test ramanometry. Clin Chem. 2022; 68: 1064–1074.

[26] He Y, Wang X, Ma B, Xu J. Ramanome technology platform for label-free screening and sorting of microbial cell factories at single-cell resolution. Biotechnol Adv. 2019; 37:107388.

[27] Monsees I, Turzynski V, Esser SP, Soares A, Timmermann LI, Weidenbach K, et al. Label-free Raman microspectroscopy for identifying prokaryotic virocells. mSystems. 2022; 7:e0150521.

[28] Pilát Z, Jonáš A, Pilátová J, Klementová T, Bernatová S, Šiler M, et al. Analysis of bacteriophage-host interaction by Raman tweezers. Anal Chem. 2020; 92: 12304–12311.

[29] Jin M, Cai L, Lu L, Yu M, Zhang R. Combined metabolomic and genomic analyses reveal phage-specific and infection stage-specific alterations to marine roseobacter metabolism. ISME Commun. 2025; 5:ycaf047.

[30] Dion MB, Oechslin F, Moineau S. Phage diversity, genomics and phylogeny. Nat Rev Microbiol. 2020; 18: 125–138.

[31] Berget SM, Mozer TJ, Warner HR. Early events after infection of Escherichia coli by bacteriophage T5. J Virol. 1976; 18: 71–79.

[32] Parker DR, Nugen SR. Bacteriophage-based bioanalysis. Annu Rev Anal Chem. 2024; 17: 393–410.

[33] Wolfram-Schauerte M, Pozhydaieva N, Viering M, Glatter T, Höfer K. Integrated omics reveal time-resolved insights into T4 phage infection of E. coli on proteome and transcriptome levels. Viruses. 2022; 14: 2502.

[34] Movasaghi Z, Rehman S, Rehman IU. Raman spectroscopy of biological tissues. Appl Spectrosc Rev. 2007; 42: 493–541.

[35] Sapers HM, Razzell Hollis J, Bhartia R, Beegle LW, Orphan VJ, Amend JP. The cell and the sum of its parts: patterns of complexity in biosignatures as revealed by deep UV Raman spectroscopy. Front Microbiol. 2019; 10: 679.

[36] Georjon H, Bernheim A. The highly diverse antiphage defence systems of bacteria. Nat Rev Microbiol. 2023; 21: 686–700.

[37] Wang X, Ren L, Diao Z, He Y, Zhang J, Liu M, et al. Robust spontaneous Raman flow cytometry for single-cell metabolic phenome profiling via pDEP-DLD-RFC. Adv Sci. 2023; 10:e2207497.

[38] Guo S, Popp J, Bocklitz T. Chemometric analysis in Raman spectroscopy from experimental design to machine learning-based modeling. Nat Protoc. 2021; 16: 5426–5459.

[39] Wang X, Xin Y, Ren L, Sun Z, Zhu P, Ji Y, et al. Positive dielectrophoresis-based Raman-activated droplet sorting for culture-free and label-free screening of enzyme function in vivo. Sci Adv. 2020; 6:eabb3521.

[40] Wang X, Wang S, Diao Z, Hou X, Gong Y, Sun Q, et al. Label-free high-throughput live-cell sorting of genome-wide random mutagenesis libraries for metabolic traits by Raman flow cytometry. Proc Natl Acad Sci USA. 2025; 122:e2503641122.

[41] Xu T, Gong Y, Su X, Zhu P, Dai J, Xu J, et al. Phenome–genome profiling of single bacterial cell by Raman-activated gravity-driven encapsulation and sequencing. Small. 2020; 16:e2001172.

[42] Jing X, Gong Y, Ren Y, Wang L, Mu R, Sun P, et al. Mining robust in situ phosphorus-accumulating organisms via single-cell RACS-Culture for rational ecosystem engineering. Water Res. 2025; 284:124025.

[43] Diao Z, Peng Q, Luo S, Kan L, Ge A, Gao W, et al. AI-powered high-throughput digital colony picker platform for sorting microbial strains by multi-modal phenotypes. Nat Commun. 2025; 16: 8769.

[44] Xu T, Li Y, Han X, Kan L, Ren J, Sun L, et al. Versatile, facile and low-cost single-cell isolation, culture and sequencing by optical tweezer-assisted pool-screening. Lab Chip. 2023; 23: 125–135.

[45] Zhang Y, Jing G, Chen R, Gong Y, Li Y, Wang Y, et al. RamEx: an R package for high-throughput microbial ramanome analyses with accurate quality assessment. Microbiome. 2026; 14: 89.

Rights & permissions

2026 The Author(s). mLife published by John Wiley & Sons Australia, Ltd on behalf of Institute of Microbiology, Chinese Academy of Sciences.